New Zealand markets close in 4 hours 6 minutes

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
40.21+0.47 (+1.18%)
At close: 04:00PM EDT
39.42 -0.79 (-1.96%)
After hours: 05:25PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
2,278,485
2,289,463
2,122,353
1,814,254
1,794,894
Operating expenses
Research development
297,943
200,084
26,289
83,036
392,609
Selling general and administrative
191,210
182,826
181,715
103,439
61,906
Total operating expenses
857,349
858,748
526,954
-808,922
430,448
Operating income or loss
1,421,136
1,430,715
1,595,399
2,623,176
1,364,446
Interest expense
175,790
166,142
157,059
268,573
279,956
Total other income/expenses net
-81,507
-76,907
235,235
84,487
408,924
Income before tax
1,210,305
1,241,201
1,701,954
2,461,419
1,517,855
Income tax expense
0
0
0
0
0
Income from continuing operations
1,210,305
1,241,201
1,701,954
2,461,419
1,517,855
Net income
602,370
619,728
975,040
2,348,535
1,377,729
Net income available to common shareholders
602,370
619,728
495,198
1,187,270
1,377,729
Basic EPS
-
-
2.51
3.35
3.89
Diluted EPS
-
-
2.51
3.35
3.89
Basic average shares
-
-
388,135
354,176
354,176
Diluted average shares
-
-
388,135
354,176
354,176
EBITDA
-
1,430,339
1,882,071
2,753,916
1,831,078